UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	May 12, 2022

Accession Number:	0001193125-22-146286
Submission Type:	POS AM
CIK: 0001593899 Company Name: Atea Pharmaceuticals, Inc. File Number: 333-261344